Ovid Therapeutics Inc (OVID)

Ovid Therapeutics Inc (OVID) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 26, 2026: market cap $441M; returns 1 day -0.2%, 1 week -0.7%, 1 year +32.2%.

Ovid Therapeutics Inc. is a New York-based biopharmaceutical company focused on developing small molecule medicines for brain conditions characterized by significant unmet medical needs, particularly neurological and neuropsychiatric disorders resulting from neuronal hyperexcitability.

Groups OVID belongs to

• Biopharmaceutical
• Biotechnology
• Healthcare
• Neurological Disorders
• CNS Disorders
• Neuroscience
• Epilepsy
• Clinical Stage Biotech
• Unmet Medical Needs
• Royalty Streams
• Drug Discovery

OVID financial model: income statement, cash flow and balance sheet